The Regulatory Recon this week had an update about an EMA Reflection Paper on the use of AI/ML in drug development:
"EMA to drug developers on AI: Carry out thorough risk assessments (Endpoints)"
I cannot locate this discussion paper, and the link in the Endpoints article that purports to direct one to it is broken. Has anyone else been able to find this paper?
Thank you!
------------------------------
Jess Ross
San Francisco CA
United States
------------------------------